1. CCR9–CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway
   Baijun Li et al, 2015, Medical Oncology CrossRef
2. The role of chemokine receptor 9/chemokine ligand 25 signaling: From immune cells to cancer cells (Review)
   Cong Wang et al, 2018, Oncology Letters CrossRef
3. Immunohistochemical staining with chemokine panel of non-specific colitis predicts future IBD diagnosis
   Aymen M. El-Saka et al, 2020, Cytokine CrossRef
4. Bufalin inhibits cell proliferation and migration of hepatocellular carcinoma cells via APOBEC3F induced intestinal immune network for IgA production signaling pathway
   Zongguo Yang et al, 2018, Biochemical and Biophysical Research Communications CrossRef
5. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis
   Rei Morikawa et al, 2021, Journal of Hepatology CrossRef
6. Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma
   Yonglong Zhong et al, 2015, Diagnostic Pathology CrossRef
7. CCR9 in cancer: oncogenic role and therapeutic targeting
   Zhenbo Tu et al, 2016, Journal of Hematology & Oncology CrossRef
8. Establishment of a Sensitive Monoclonal Antibody Against Mouse CCR9 (C9Mab-24) for Flow Cytometry
   Hiyori Kobayashi et al, 2023, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy CrossRef
9. C‐C Motif Chemokine Receptor 9 Exacerbates Pressure Overload–Induced Cardiac Hypertrophy and Dysfunction
   Zhengxi Xu et al, 2016, Journal of the American Heart Association CrossRef
10. CCR9 and CCL25: A review of their roles in tumor promotion
    Baoping Xu et al, 2020, Journal of Cellular Physiology CrossRef
11. Exploration of prognostic and treatment markers in hepatocellular carcinoma via GPCR-related genes analysis
    Yuxin Wang et al, 2024, Heliyon CrossRef
12. C9Mab-1: An Anti-Mouse CCR9 Monoclonal Antibody for Immunocytochemistry
    Masaki Saito et al, 2022, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy CrossRef
13. Chemokines and their receptors play important roles in the development of hepatocellular carcinoma
    Chun-Min Liang, 2015, World Journal of Hepatology CrossRef
14. Modulatory effects of G protein–coupled receptor in hepatocellular carcinoma
    Vidya Murugesan et al, 2022, Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma CrossRef
15. Activated fibroblasts induce immune escape of TSCC through CCL25/AKT pathway
    Yiting Li et al, 2024, Oral Diseases CrossRef
16. Development of Anti-Human CC Chemokine Receptor 9 Monoclonal Antibodies for Flow Cytometry
    Ren Nanamiya et al, 2021, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy CrossRef
17. Small HBV surface antigen drives regorafenib resistance in HCC via KIAA1429‐dependent m6A modification of CCR9
    Zhao Lv et al, 2024, Journal of Medical Virology CrossRef
18. Gd-EOB-DTPA-enhanced magnetic resonance imaging combined with T1 mapping predicts the degree of differentiation in hepatocellular carcinoma
    Zhenpeng Peng et al, 2016, BMC Cancer CrossRef
19. Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside
    Gabriel Siracusano et al, 2020, Vaccines CrossRef
20. Emerging Roles of G Protein-Coupled Receptors in Hepatocellular Carcinoma
    Wen-Ting Peng et al, 2018, International Journal of Molecular Sciences CrossRef